Charles Ryhee
Stock Analyst at TD Cowen
(2.42)
# 2,457
Out of 5,116 analysts
17
Total ratings
60%
Success rate
10.88%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $79.61 | +0.49% | 5 | Nov 25, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $828.26 | -21.28% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $150.02 | +13.32% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $4.12 | +1,332.04% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $208.29 | -65.43% | 1 | Aug 16, 2022 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $7.12 | +2,540.45% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $14.91 | +94.50% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $79.61
Upside: +0.49%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $828.26
Upside: -21.28%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $150.02
Upside: +13.32%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $4.12
Upside: +1,332.04%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $208.29
Upside: -65.43%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $7.12
Upside: +2,540.45%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $14.91
Upside: +94.50%